Incyclix Bio, LLC — Form D
Incyclix Bio, LLC of Durham, NC, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-22. The offering totals $20.0M, of which $11.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-08-22
- Form: D
- Accession: 0001916275-25-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $11.2M
- Remaining: $8.8M
- Investors: 4
- Date of first sale: 2025-08-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-555568
Issuer
- Name: Incyclix Bio, LLC
- CIK: 0001916275
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 600 PARK OFFICES DRIVE, Durham, NC, 27713
- Phone: (919) 328-0003
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Fredric N Eshelman | Director | Durham, NC |
| Patrick Roberts | Director | Durham, NC |
| Norman N Sharpless | Director | Durham, NC |
| Fredric N Eshelman | Executive Officer | Durham, NC |
| Patrick Roberts | Executive Officer | Durham, NC |
| Sid N Subramony | Director | Research Triangle Park, NC |
| Patrick N Roberts | Director | Research Triangle Park, NC |
| Patrick N Roberts | Executive Officer | Research Triangle Park, NC |
Other filings by this issuer (2)
More